In the CGGA cohort, high UBE2S expression level (> median value) was significantly associated with worse prognosis compared with low expression of UBE2S in LGG patients (p < 0.001), whereas this association was not observed in GBM patients (n = 325, p = 0.3924, Figures S2C, D). The gene discussed is UBE2S; the disease is glioblastoma.